US2023389576A1PendingUtilityA1

Methods of diagnosing and treating chronic kidney disease

70
Assignee: MARS INCPriority: May 31, 2017Filed: Aug 17, 2023Published: Dec 7, 2023
Est. expiryMay 31, 2037(~10.8 yrs left)· nominal 20-yr term from priority
Inventors:Vincent BiourgeJonathan T. ElliottDirk Hendrik Nicolaas Van Den BroekRosanne Ellen JepsonYu-Mei Chang
A23K 20/24A23K 50/40A23K 10/00G01N 33/84G01N 2800/347A61K 33/06A61P 13/12G01N 33/6872G01N 33/53G01N 2333/50
70
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The presently disclosed subject matter relates to methods of diagnosing and treating chronic kidney disease (CKD) in an animal, comprising determining the amount of magnesium in a sample of the animal and providing the animal with a treatment regimen. In certain embodiments, the treatment regimen comprises administering an effective amount of magnesium.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A pet food composition comprising magnesium or a salt thereof in an amount of about 10 mg to about 1000 mg per daily serving or unit dosage. 
     
     
         2 . The pet food composition of  claim 1 , wherein the amount of magnesium is in an amount of about 0.001% to about 10% by weight of the pet food composition. 
     
     
         3 . The pet food composition of  claim 1 , wherein the amount of the magnesium is no more than about 0.25% weight by weight of the pet food composition. 
     
     
         4 . The pet food composition of  claim 1 , wherein the pet food composition further comprises an additional active agent. 
     
     
         5 . The pet food composition of  claim 4 , wherein the additional active agent can be selected from a group comprising a nutritional agent, a beta-blocker, an agent that reduces blood pressure, or combinations thereof. 
     
     
         6 . The pet food composition of  claim 1 , wherein the pet food composition further comprises additives. 
     
     
         7 . The pet food composition of  claim 6 , wherein the additives are present in an amount of up to about 5% by dry basis of the composition. 
     
     
         8 . The pet food composition of  claim 1 , wherein the magnesium is in a magnesium coordination complex. 
     
     
         9 . The pet food composition of  claim 8 , wherein the magnesium coordination complex comprises a chlorophyll selected from the group comprising chlorophyll a, chlorophyll b, chlorophyll c1, chlorophyll c2, chlorophyll d, chlorophyll f, or combinations thereof. 
     
     
         10 . The pet food composition of  claim 1 , wherein the magnesium is a magnesium salt. 
     
     
         11 . The pet food composition of  claim 10 , wherein the magnesium salt comprises an anion bonded via ionic bond with Mg 2+ . 
     
     
         12 . The pet food composition of  claim 10 , wherein the magnesium salt comprises an acetate salt, a trifluoroacetate salt, or a formate salt. 
     
     
         13 . The pet food composition of  claim 10 , wherein the magnesium salt is magnesium glycinate. 
     
     
         14 . The pet food composition of  claim 1 , wherein the magnesium is an inorganic magnesium salt. 
     
     
         16 . The pet food composition of  claim 1 , wherein the magnesium is an organic magnesium salt. 
     
     
         17 . The pet food composition of  claim 1 , wherein the pet food composition is a dietary supplement, an oral supplement, treat, dry pet food, and/or wet pet food. 
     
     
         18 . The pet food composition of  claim 17 , wherein the wet pet food is in a canned form. 
     
     
         19 . The pet food composition of  claim 17 , wherein the dry pet food is kibble. 
     
     
         20 . The pet food composition of  claim 1 , wherein the pet food composition is a cat food composition.

Join the waitlist — get patent alerts

Track US2023389576A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.